Yu Nakagawa1, Hikaru Sasaki2, Kentaro Ohara3, Taketo Ezaki1, Masahiro Toda1, Takayuki Ohira1, Takeshi Kawase1, Kazunari Yoshida1. 1. Department of Neurosurgery, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan. 2. Department of Neurosurgery, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan. Electronic address: hsasaki@a5.keio.jp. 3. Department of Pathology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Abstract
OBJECTIVE: The purpose of this study was to clarify the clinical and molecular characteristics associated with long-term survival in patients with glioblastoma. METHODS: We analyzed the characteristics of 96 glioblastoma patients. Long-term survivors (LTSs) were classified into moderate LTSs (mLTSs), who survived >3 years, and LTSs, who survived >5 years, and compared with short-term survivors (STSs). Clinical and molecular factors were investigated. RESULTS: Younger age, better recursive partitioning analysis class, lack of subventricular zone (SVZ) involvement, promoter methylation of the O6-methylguanine-DNA methyltransferase (MGMT) gene, and loss of 19q were associated with mLTSs as compared with STSs. After adjustment for these factors, younger age and MGMT methylation remained independently associated with mLTSs. Younger age, better recursive partitioning analysis class, lack of SVZ involvement, and loss of 19q were associated with LTSs as compared with STSs. After adjustment, younger age and better preoperative Karnofsky performance scale (KPS) score remained independently associated with LTSs. Kaplan-Meier analyses revealed that younger age (<50 years), better preoperative KPS score (≥70), lack of SVZ involvement, and loss of 19q were associated with longer overall survival. In the multivariate analysis, only age was significantly associated with overall survival. CONCLUSIONS: Younger age and better preoperative KPS score were the characteristics associated with LTSs as compared with STSs. MGMT promoter methylation was associated with mLTSs, but not with LTSs. In addition, lack of SVZ involvement and loss of 19q might be prognostic for longer survival.
OBJECTIVE: The purpose of this study was to clarify the clinical and molecular characteristics associated with long-term survival in patients with glioblastoma. METHODS: We analyzed the characteristics of 96 glioblastomapatients. Long-term survivors (LTSs) were classified into moderate LTSs (mLTSs), who survived >3 years, and LTSs, who survived >5 years, and compared with short-term survivors (STSs). Clinical and molecular factors were investigated. RESULTS: Younger age, better recursive partitioning analysis class, lack of subventricular zone (SVZ) involvement, promoter methylation of the O6-methylguanine-DNA methyltransferase (MGMT) gene, and loss of 19q were associated with mLTSs as compared with STSs. After adjustment for these factors, younger age and MGMT methylation remained independently associated with mLTSs. Younger age, better recursive partitioning analysis class, lack of SVZ involvement, and loss of 19q were associated with LTSs as compared with STSs. After adjustment, younger age and better preoperative Karnofsky performance scale (KPS) score remained independently associated with LTSs. Kaplan-Meier analyses revealed that younger age (<50 years), better preoperative KPS score (≥70), lack of SVZ involvement, and loss of 19q were associated with longer overall survival. In the multivariate analysis, only age was significantly associated with overall survival. CONCLUSIONS: Younger age and better preoperative KPS score were the characteristics associated with LTSs as compared with STSs. MGMT promoter methylation was associated with mLTSs, but not with LTSs. In addition, lack of SVZ involvement and loss of 19q might be prognostic for longer survival.
Authors: Arpan Patel; Evgenii Belykh; Eric J Miller; Laeth L George; Nikolay L Martirosyan; Vadim A Byvaltsev; Mark C Preul Journal: Surg Neurol Int Date: 2018-08-10
Authors: Sharon Berendsen; Emma van Bodegraven; Tatjana Seute; Wim G M Spliet; Marjolein Geurts; Jeroen Hendrikse; Laurent Schoysman; Willemijn B Huiszoon; Meri Varkila; Soufyan Rouss; Erica H Bell; Jérôme Kroonen; Arnab Chakravarti; Vincent Bours; Tom J Snijders; Pierre A Robe Journal: PLoS One Date: 2019-10-11 Impact factor: 3.240
Authors: Arshad A Pandith; Iqbal Qasim; Shahid M Baba; Aabid Koul; Wani Zahoor; Dil Afroze; Adil Lateef; Usma Manzoor; Ina A Bhat; Dheera Sanadhya; Abdul R Bhat; Altaf U Ramzan; Fozia Mohammad; Iqra Anwar Journal: Future Sci OA Date: 2020-12-09
Authors: Huy Gia Vuong; Thu Quynh Nguyen; Tam N M Ngo; Hoang Cong Nguyen; Kar-Ming Fung; Ian F Dunn Journal: BMC Cancer Date: 2020-09-21 Impact factor: 4.430